Concepedia

Seth J. Baum

SJ

60

Publications

8K

Citations

35

H-Index

1980

Active since

Affiliations

Florida Atlantic University(Current)

Sheba Medical Center

University of Kansas Medical Center

Université de Montréal

Tel Aviv University

Seth J. Baum is an author at Florida Atlantic University specializing in medicine, pharmacology, and cardiovascular disease.

ORCID

Top concepts

Publications per year

1980–2025

60

Publications

60

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy et al. · New England Journal of Medicine · 2024 · 1.4K citations · Full text

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk, Ioanna Gouni‐Berthold et al. · New England Journal of Medicine · 2020 · 924 citations · Full text

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Stephen A. Harrison, Mustafa R. Bashir, Cynthia D. Guy et al. · The Lancet · 2019 · 733 citations

, , +10

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

Milton Packer, Michael R. Zile, Christopher M. Kramer et al. · New England Journal of Medicine · 2024 · 574 citations

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer et al. · New England Journal of Medicine · 2022 · 451 citations · Full text

Rows per page

1–5 of 60